Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • Diabetes and Endocrinology
  • Diabetes and Endocrinology Perspective
  • Prediabetes-The Sugary...

Prediabetes-The Sugary Iceberg Calls for Early Interventions With Metformin

Dr Soumya S InamadarWritten by Dr Soumya S Inamadar Published On 2024-08-01T12:47:45+05:30  |  Updated On 1 Aug 2024 4:54 PM IST
Prediabetes-The Sugary Iceberg Calls for Early Interventions With Metformin
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

Prediabetes, often a precursor to type 2 diabetes(T2D) and cardiovascular disease, is a harbinger of metabolic syndrome. Its high conversion rate to T2D of approximately 25% depicts it as the “sugary” iceberg (1). In primary care, prediabetes is a critical stage for intervention that gives a rare opportunity for early and efficient management (2).

Indians Are on High Pre-Diabetes Risk: The ICMR-INDIAB-17 (Indian Council of Medical Research–India Diabetes) data showed that the prevalence of prediabetes and diabetes in India was 15.3% and 11.49%, affecting 136 million and 101 million, respectively (3). A 10-year population-based prospective cohort study (n=1787), which assessed the incidence of dysglycaemia in Asian Indians, also showed that 55.7% of pre-diabetes individuals are converted to diabetes (p>0.05). With prediabetes affecting such a significant proportion of the population and increasing their risk for T2D, understanding the magnitude of this risk is crucial (4). Age and body mass index, physical inactivity, family history of T2D, hypertension (HT), and history of gestational diabetes are some common factors that predict prediabetes in Indians (5).

Benefits of Early Intervention:

Diagnosis, medication, lifestyle changes, and screening are all part of diabetes prevention strategies for high-risk individuals or populations. Apart from studies that demonstrate the benefits of lifestyle changes, several trials showed the significant effects of drug treatment in reducing the progression of T2D in high-risk individuals (6).

Early intervention can prevent the risk of diabetes by as much as 50% if normoglycemia can be achieved (7). Furthermore, the risk of microvascular complications such as retinopathy was reduced by 38% and the risk of cardiovascular disease (CVD) by 17% with early intervention (medication and lifestyle changes in prediabetes) (8).

The Diabetes Prevention Program Outcomes Study (DPPOS) showed a 28% lower incidence of the composite microvascular complications (retinopathy, nephropathy, and/or neuropathy) in participants who did not develop T2D, across treatment groups who had been randomised to intensive lifestyle intervention and followed for 15 years after randomization (9).

The 30-year follow-up of the Da Qing Study showed a 40% reduction in retinopathy despite the study cohort achieving a small average weight loss of 1.8 kg throughout the intervention period (10). Overall, there is mounting evidence that individuals with prediabetes are susceptible to the traditional problems of diabetes, which can be avoided with early intensification.

Metformin- Approved Agent in Prediabetes

Although both intensive lifestyle interventions have proven to be effective for the prevention or delay of diabetes in people with prediabetes,but challeging to adhere to, clinical trials have provided evidence that metformin is effective in preventing diabetes, particularly in younger, overweight patients (5).

A recently published 2024 meta-analysis analysing the effectiveness of metformin in delaying the progression of pre-diabetes to type 2 diabetes showed a 22% relative risk reduction with metformin compared to lifestyle modification or placebo, with a 95% confidence interval of 0.71–0.86. The result also noted that the metformin dose (low versus high) did not influence the outcome [p = 0.39] (1).

The Drug Controller General of India (DCGI) has approved metformin to prevent and delay T2D in prediabetes. Metformin has a strong safety record and positive effects on lipid levels and body mass index [BMI] (3). Metformin therapy for the prevention of T2D should be considered in those with prediabetes, especially those with BMI above 35 kg/m2, age above 60, and women with prior gestational diabetes mellitus, where lifestyle intervention is insufficiently effective in reducing body weight and improving glucose tolerance (3).

Key Takeaways

  • Prediabetes not only signals the onset of metabolic syndrome but also presents a window to intervene before the development of more severe conditions like type 2 diabetes and cardiovascular disease.
  • Prediabetes, with its high conversion rate of approximately 25%, depicts as the “sugary” iceberg.
  • Asian Indians have a high risk of developing type 2 diabetes, with 55.7% of pre-diabetes individuals converted to diabetes.
  • Early intervention can prevent diabetes in more than 50% of cases, if normoglycemia can be attained. It can also reduce the risk of CVD by 17% and microvascular complications, such as retinopathy, by 40%.
  • Metformin is an effective drug for preventing diabetes. It has a strong safety record and positive effects on lipid levels and body mass index.
  • The Drug Controller General of India (DCGI) approved metformin to prevent and delay T2D in prediabetes.

References:

1. Samit Ghosal, Surekha Tippisetty, Subhadra Polisetti, Krishna G. Seshadri. Metformin for the Prevention of Prediabetes Progression to Type 2 Diabetes: A Systematic Review and Meta-Analysis. Clinical Diabetology 2024, DOI: 10.5603/cd.99821

2. Gabison, Jonathan G. “Is Prediabetes Overdiagnosed? No: A Clinician's Perspective.” Annals of family medicine vol. 22,3 251-253. 28 May. 2024, doi:10.1370/afm.3101

3. Anjana, Ranjit Mohan et al. “Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study (ICMR-INDIAB-17).” The Lancet. Diabetes & endocrinology vol. 11,7 (2023): 474-489. doi:10.1016/S2213-8587(23)00119-5

4. Gupta R, Jayant SS, Rastogi A, Bhadada SK, Bhansali A, Sachdeva N, Ram S. Incidence and risk factors for dysglycaemia in Asian-Indians: a 10-year population-based prospective cohort study. Postgrad Med J. 2023 May 19;99(1169):176-182. doi: 10.1136/postgradmedj-2021-141243. PMID: 37222055.

5. Das AK, Mohan V, Ramachandran A, et al. An Expert Group Consensus Statement on “Approach and Management of Prediabetes in India”. J Assoc Physicians India 2022;70(12):69–78.

6. Del Prato, S., Bianchi, C., Miccoli, R. and Penno, G. (2007), Pharmacological intervention in prediabetes: considering the risks and benefits. Diabetes, Obesity and Metabolism, 9: 17-22. https://doi.org/10.1111/j.1463-1326.2007.00766.x

7. Perreault L. Prediabetes. [Updated 2022 Mar 3]. In: Feingold KR, Anawalt B, Blackman MR, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK538537/

8. An X, Zhang Y, Sun W, et al. Early effective intervention can significantly reduce all-cause mortality in prediabetic patients: a systematic review and meta-analysis based on high-quality clinical studies. Front Endocrinol (Lausanne). 2024;15:1294819. Published 2024 Mar 1. doi:10.3389/fendo.2024.1294819

9. Diabetes Prevention Program Research Group. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study. Lancet Diabetes Endocrinol. 2015;3(11):866–875

10. Gong Q, Zhang P, Wang J, Ma J, An Y, Chen Y, Zhang B, Feng X, Li H, Chen X, Cheng YJ, Gregg EW, Hu Y, Bennett PH, Li G. Da Qing Diabetes Prevention Study G. Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study. Lancet Diabetes Endocrinol. 2019;7(6):452–461.

prediabetesearly treatment prediabetesdiabetespre diabetest2dmetforminmetformin prediabetesglycometglycomet prediabetesprediabetes indiadr soumya s inamadar
Dr Soumya S Inamadar
Dr Soumya S Inamadar

    Dr Soumya S Inamadar is an Endocrinologist. Dr Inamadar did her MBBS from Bangalore Medical College and Research Institute, MD(General Medicine) from University College of Medical Sciences, Delhi and DrNB (Endocrinology) from CARE Hospital, Banjara Hills, Hyderabad. Dr Inamadar is currently working at Dr Palled Super Speciality Clinic and SeCURE Hospital in Hubli.

    Show Full Article
    Next Story

    Editorial

    National Consensus 2025 on Role of Bisoprolol Across CV Continuum in Women: Top 10 Takeaways

    National Consensus 2025 on Role of Bisoprolol Across CV Continuum in Women: Top 10 Takeaways

    Relevance of Pioglitazone in Indian T2DM Care Continuum

    Relevance of Pioglitazone in Indian T2DM Care Continuum

    Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study

    Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study

    First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan

    First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan

    Re-visiting the Role of Pneumococcal Vaccination in Patients with Cardiovascular Diseases

    Re-visiting the Role of Pneumococcal Vaccination in Patients with Cardiovascular Diseases

    View All

    Journal Club Today

    Study Reveals Why Your Immune System Works Better in Daylight

    Study Reveals Why Your Immune System Works Better in Daylight

    View All

    Health News Today

    Health Bulletin 28/May/2025

    Health Bulletin 28/May/2025

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok